The effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in men with chronic spinal cord injury: a clinical trial von Mohammadi, V, Khalili, M, Eghtesadi, S, Dehghani, S, Jazayeri, S, Aghababaee, S K, Sabour, H, Saberi, H, Eghtesadi, M, Gohari, M R

Volltext

The effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in men with chronic spinal cord injury: a clinical trial von Mohammadi, V, Khalili, M, Eghtesadi, S, Dehghani, S, Jazayeri, S, Aghababaee, S K, Sabour, H, Saberi, H, Eghtesadi, M, Gohari, M R

Volltext

Erratum: The effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in men with chronic spinal cord injury: a clinical trial von Mohammadi, V, Khalili, M, Eghtesadi, S, Dehghani, S, Jazayeri, S, Aghababaee, S K, Sabour, H, Saberi, H, Eghtesadi, M, Gohari, M R

Volltext

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect? von Etemadifar, Masoud, Sedaghat, Nahad, Aghababaee, Ali, Kargaran, Parisa K, Maracy, Mohammad Reza, Ganjalikhani-Hakemi, Mazdak, Rayani, Milad, Abhari, Amir Parsa, Khorvash, Reza, Salari, Mehri, Nouri, Hosein

Volltext

MRI signs of CNS demyelinating diseases von Etemadifar, Masoud, Ashourizadeh, Helia, Nouri, Hosein, Kargaran, Parisa K, Salari, Mehri, Rayani, Milad, Aghababaee, Ali, Abhari, Amir Parsa

Volltext